EVALUATION OF STRUCTURE AND CAUSES FOR SWITCHING BDMARDS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Bobkova, A. O. [1 ]
Potapova, A. S. [1 ]
Sholkina, P. A. [1 ]
Karateev, A. E. [1 ]
Polishchuk, E. Y. U. [1 ]
Lila, A. M. [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2024年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P219
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [41] COMPARING THE EFFICACY OF THE BDMARD SWITCHER GROUP AND JAK CYCLER GROUP IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH FAILURE TO THE JAK INHIBITORS
    Yamasaki, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 734 - 735
  • [42] CYCLING OF JAK-INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SINGLE-CENTRE EXPERIENCE
    Vassallo, C.
    Sammut, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1334 - 1335
  • [43] Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors
    Cito, Andrea
    Fornaro, Marco
    Carenza, Angela
    Anelli, Maria Grazia
    Scioscia, Crescenzio
    Iannone, Florenzo
    Lopalco, Giuseppe
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [44] SAFETY OF JAK INHIBITORS IN PATIENTS WITH ARTHRITIS RHEUMATOID UNDER REAL-LIFE CONDITIONS
    Velloso Feijoo, M. L.
    Cid Boza, N.
    Perez, M. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1478 - 1478
  • [45] CANCERS AND CARDIOVASCULAR DISEASES IN PATIENTS WITH SEROPOSITIVE RHEUMATOID ARTHRITIS TREATED WITH JAK INHIBITORS AND BIOLOGICS
    Ahn, S. S.
    Han, M.
    Jung, I.
    Kim, H. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 87 - 88
  • [46] CAN JAK 2 INHIBITORS IMPROVE UIP IN RHEUMATOID ARTHRITIS PATIENTS? FOOD FOR THOUGHT!
    Kasavkar, Ganesh
    Woodhead, Felix
    Shakespeare, Joanna
    Dubey, Shirish
    RHEUMATOLOGY, 2019, 58 : 99 - 99
  • [47] Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
    Kotyla, Przemyslaw J.
    Islam, Md Asiful
    Engelmann, Malgorzata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 17
  • [48] JAK INHIBITORS IN REFRACTORY AND AT-RISK COMORBID PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE
    Al Tabaa, O.
    Hecquet, S.
    Thomas, M.
    Carves, S.
    Combier, A.
    Richard, C. Miceli
    Fogel, O.
    Molto, A.
    Allanore, Y.
    Avouac, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1420 - 1420
  • [49] EFFICACY OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST GENERATION JAK INHIBITORS
    Kamiya, M.
    Mori, S.
    Yamazaki, K.
    Togawa, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [50] Imidazopyridazine derivatives as pan-JAK inhibitors for rheumatoid arthritis
    Bach, Jordi
    Balague, Cristina
    Calaf, Elena
    Godessart, Nuria
    Lozoya, Estrella
    Maldonado, Monica
    Orellana, Adela
    Vidal, Bernat
    Vidal, Laura
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
12345